Skip to main navigation Skip to search Skip to main content

A Phase 2, Single-Arm Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Project: Research

Project Details

StatusActive
Effective start/end date06/17/26 → 06/16/27

Funding

  • Incyte Corporation: $36,500.00